<SEC-DOCUMENT>0001415889-25-014398-index.html : 20250523
<SEC-HEADER>0001415889-25-014398.hdr.sgml : 20250523
<ACCEPTANCE-DATETIME>20250523134529
ACCESSION NUMBER:		0001415889-25-014398
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20250521
FILED AS OF DATE:		20250523
DATE AS OF CHANGE:		20250523

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Pruzanski Mark
		CENTRAL INDEX KEY:			0001559569
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38692
		FILM NUMBER:		25980999

	MAIL ADDRESS:	
		STREET 1:		C/O INTERCEPT PHARMACEUTICALS, INC.
		STREET 2:		18 DESBROSSES ST.
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Equillium, Inc.
		CENTRAL INDEX KEY:			0001746466
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				821554746
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		2223 AVENIDA DE LA PLAYA
		STREET 2:		SUITE 105
		CITY:			LA JOLLA
		STATE:			CA
		ZIP:			92037
		BUSINESS PHONE:		(858) 412-5302

	MAIL ADDRESS:	
		STREET 1:		2223 AVENIDA DE LA PLAYA
		STREET 2:		SUITE 105
		CITY:			LA JOLLA
		STATE:			CA
		ZIP:			92037
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>form4-05232025_050525.xml
<TEXT>
Document 1 - file: form4-05232025_050525.html

Document 1 - RAW XML: form4-05232025_050525.xml

</DOCUMENT>
</SEC-DOCUMENT>